FundaMental Pharma
PrivateLast Round
Seed
Apr 11, 2024
Total Funding Raised
$13.29M
Company Overview
FundaMental Pharma is a drug discovery company developing a new class of drugs that safely counteract glutamate neurotoxicity, a common cause of neurodegeneration, with an initial focus on amyotrophic lateral sclerosis (ALS) and treatment-resistant depression.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Mental Health, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FundaMental Pharma Comps
Public and private peers based on sector, stage, and business model.
FundaMental Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 11, 2024 | ||||
| Seed | Nov 17, 2022 | ||||
| Seed | Jun 23, 2021 |
FundaMental Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thuja Capital | Seed |
| Novartis Venture Fund | Seed |
| BioGeneration Ventures | Seed |
| Coparion | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2026
Will attend the Bio-Neuroscience Conference.
FundaMental Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FundaMental Pharma's valuation, stock price, and market status.
